Abstract

AbstractEmail is the primary method of communication with authors of scientific publications. This study sought to measure the reliability, over time, of contact email addresses from biomedical publications, particularly depending on email type. Emails were written to randomly selected email addresses from publications in MEDLINE, and email bounce rates were modeled probabilistically. The use of personal email addresses was quantified and compared to the use of other types of email addresses. Eighteen percent of authors' contact email addresses in MEDLINE were estimated to be invalid. A steadily growing share of email addresses was personal: 32% of all new email addresses in MEDLINE in 2018 were of this kind. These email addresses were less likely to be invalid than email addresses from other types of providers. While the percentage of invalid email addresses was significant, it was lower than previously estimated. Personal email addresses are taking an increasingly more important role by supplying more reliable email addresses to scientists. To mitigate the problem of invalid email addresses, institutions should provide email forwarding, scientific directories should offer the possibility of contacting authors, or scientific authors should use more stable email addresses.

Highlights

  • It is well known to online marketers that email addresses go “stale” (i.e., become invalid) over time

  • It is well known to online marketers that email addresses go “stale” over time

  • We emailed 265 authors randomly selected from the MEDLINE database

Read more

Summary

Introduction

It is well known to online marketers that email addresses go “stale” (i.e., become invalid) over time. Scientific authors change email address over time. We have calculated that approximately 18% of all authors’ contact email addresses in MEDLINE are invalid. Institutions should provide email forwarding and scientific authors should use more stable email addresses.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.